A Dutch court ruled that Microsoft co-founder Bill Gates could face trial in the Netherlands, following a case filed by seven individuals claiming to have suffered injuries from COVID-19 vaccines. The case,
Artificial intelligence tools increasingly used in healthcare could worsen outcomes for women and ethnic minorities, according to research highlighted by the Financial Times. Studies suggest that large language models (LLMs) employed to
More
Artificial intelligence is no longer just drawing cats or writing emails—it’s now writing genomes. A team of researchers from Stanford University and the Arc Institute in Palo Alto, California, say they have
More
A groundbreaking artificial intelligence model, Delphi-2M, can forecast a person’s risk of developing more than 1,000 diseases — in some cases providing predictions up to 20 years ahead. The study, published today
More
Brazil is taking an ambitious two-pronged approach to combat dengue, a mosquito-borne virus that kills thousands in South America each year and is spreading rapidly across the region. Health authorities are deploying
More
This week, scientists gathered in Manchester for a conference on aging to share groundbreaking research aimed at understanding the biological mechanisms that drive aging and age-related diseases. Experts presented studies that investigate
More
Scientists have taken a major step forward in the search for a lasting treatment for type 1 diabetes, offering new hope to millions who currently rely on daily insulin injections. In a
More
Scientists have identified a previously unknown immune cell in fat tissue that may contribute to chronic inflammation as organisms age, according to a new study published in Nature Aging. The discovery, based
More
A comprehensive analysis involving over 56 million people has found that long-term exposure to fine air pollutants significantly increases the risk of developing Lewy body dementia — the third most common form
More
Traumatic injuries to the central nervous system (CNS), including traumatic brain injury (TBI) and spinal cord injury (SCI), remain a major medical challenge due to oxidative damage and neuroinflammation. Current treatments are
More
The US Food and Drug Administration (FDA) has suspended the license for Valneva’s chikungunya vaccine, IXCHIQ, effective immediately, following the emergence of four new reports of serious adverse events (SAEs) consistent with
More